Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-021160
Filing Date
2022-08-04
Accepted
2022-08-04 17:31:05
Documents
58
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aveo-20220630.htm   iXBRL 10-Q 1876826
2 EX-31.1 aveo20220630ex311.htm EX-31.1 9815
3 EX-31.2 aveo20220630ex312.htm EX-31.2 9808
4 EX-32.1 aveo20220630ex321.htm EX-32.1 4625
5 EX-32.2 aveo20220630ex322.htm EX-32.2 4619
  Complete submission text file 0001628280-22-021160.txt   7801743

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aveo-20220630.xsd EX-101.SCH 55856
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aveo-20220630_cal.xml EX-101.CAL 60963
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aveo-20220630_def.xml EX-101.DEF 253801
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aveo-20220630_lab.xml EX-101.LAB 646242
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aveo-20220630_pre.xml EX-101.PRE 399889
52 EXTRACTED XBRL INSTANCE DOCUMENT aveo-20220630_htm.xml XML 1240251
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

EIN.: 043581650 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34655 | Film No.: 221137911
SIC: 2834 Pharmaceutical Preparations